
Orchid Pharma Ltd. (ORCHPHARMA): Orchid Pharma Share Price Rises 6.04% Today as Market Cap Stands at Rs 5,923.25 Cr
Updated: 21 Sept 2026 • 11:21 am
Posted by:

Orchid Pharma Share Price is in focus after the stock rose 6.04% to Rs 1,048.85 on 21 September 2026. The company’s market capitalisation stands at Rs 5,923.25 Cr, and the day’s move took the stock above its previous close of Rs 989.10. The session opened at Rs 995.85, touched a low of Rs 991.90 and finished at the day’s high of Rs 1,048.85, while turnover stood at Rs 0.61 Cr.
The supplied data confirms a clear same-day price rise, but it does not establish a company-specific catalyst. For readers tracking Orchid Pharma Share Price Today, the useful context is the combination of the day’s price range, the valuation metrics and the company’s position in Healthcare and Pharmaceuticals & Drugs. In this Orchid Pharma Stock News update, Univest is focusing on what the numbers show, not on unsupported cause-and-effect claims.
For investors scanning Orchid Pharma Share Price Live or Orchid Pharma Share Price News, the next reference points are the company’s high P/E, low return ratios, the sector benchmark and the peer set. Univest also places this move within broader Stock Market Today and Share Market Today searches, where same-day stock performance often draws interest across Stocks in News and Top Gainers Today lists.
Orchid Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,048.85 |
| Previous Close | Rs 989.1 |
| Today's Move | Rs 59.75 (+6.04%) |
| Open | Rs 995.85 |
| High | Rs 1,048.85 |
| Low | Rs 991.9 |
| Turnover | Rs 0.61 crore |
| Market Capitalisation | Rs 5,923.25 crore |
| Market Cap Category | Mid Cap |
Orchid Pharma Ltd. (ORCHPHARMA) rose to Rs 1,048.85 from the previous close of Rs 989.1, a move of Rs 59.75 or 6.04%. The stock opened at Rs 995.85, reached a high of Rs 1,048.85, recorded a low of Rs 991.9.
Orchid Pharma Share Price today moved from Rs 989.10 at the previous close to Rs 1,048.85, a gain of Rs 59.75 or 6.04%. The stock opened at Rs 995.85, traded between Rs 991.90 and Rs 1,048.85, and ended at the day’s high. Turnover for the session was Rs 0.61 Cr. Univest notes that the data confirms a same-day share price rise, but it does not establish a company-specific reason for the move. The session therefore stands out as a factual price event rather than a stated event trigger.
Orchid Pharma Ltd. (ORCHPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,923.25 crore |
| P/E Ratio | 683.5x |
| P/B Ratio | 3.78x |
| ROE | 0.7% |
| ROCE | 1.11% |
| EPS | Rs 1.45 |
| Book Value Per Share | Rs 261.65 |
| Dividend Yield | 0% |
Orchid Pharma Ltd. (ORCHPHARMA) fundamental metrics show P/E 683.5x, P/B 3.78x, ROE 0.7%, ROCE 1.11%. These figures provide context only and are not a buy or sell signal.
Orchid Pharma Ltd. has a market capitalisation of Rs 5923.25 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 683.5x, P/B at 3.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 0.7% and ROCE of 1.11%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 1.45, book value per share of Rs 261.65, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 683.5x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 3.78x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 0.7% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 1.11% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 5,923.25 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
Orchid Pharma Ltd. (ORCHPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Orchid Pharma Ltd. (ORCHPHARMA) has a P/E ratio of 683.5x, which is above the benchmark median of 32.87x, a difference of +1,979.4%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Orchid Pharma Ltd. (ORCHPHARMA) has a ROE of 0.7%, which is below the benchmark median of 11.7%, a difference of -94.02%. Orchid Pharma Ltd. (ORCHPHARMA) has a ROCE of 1.11%, which is below the benchmark median of 13.46%, a difference of -91.75%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Orchid Pharma Ltd. (ORCHPHARMA) has a P/E ratio of 683.5x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 0.7% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 1.11% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Orchid Pharma Ltd. (ORCHPHARMA) has a market capitalisation of Rs 5,923.25 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Orchid Pharma
- Orchid Pharma Share Price rose 6.04% today to Rs 1,048.85 after closing at Rs 989.10 yesterday.
- The session’s high was Rs 1,048.85, equal to the day’s closing price, after an open of Rs 995.85 and a low of Rs 991.90.
- The market capitalisation stands at Rs 5,923.25 Cr, which places the company above the sector median market cap in the supplied benchmark.
- The P/E ratio is 683.5, the P/B ratio is 3.78, the EPS is Rs 1.45 and book value is Rs 261.65.
- Orchid Pharma’s ROE of 0.70% and ROCE of 1.11% sit below the supplied sector median and peer figures.
About Orchid Pharma
Orchid Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not break out product-wise revenue, segment mix or company-specific operating lines, so the clearest factual description is that it is a listed pharmaceutical company tracked on NSE and BSE under the symbol ORCHPHARMA. Its current market capitalisation is Rs 5,923.25 Cr.
From the available financial context, Orchid Pharma Share Price is being viewed alongside earnings, book value and return ratios rather than through business-segment disclosure. That makes Orchid Pharma Stock News today more about relative valuation and company-wide financial metrics than about operating detail. Univest covers the stock as part of its broader Company Overview and Market Update flow for healthcare names.
Track Orchid Pharma Share Price on Univest
Use Orchid Pharma Ltd. (ORCHPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Orchid Pharma Share Price on Univest for live share price updates, Orchid Pharma Stock News, Orchid Pharma Latest News, Orchid Pharma Shareholding Pattern, financial ratios, company fundamentals, 52-week levels and market insights. Univest also helps readers compare Orchid Pharma Share Price Today with peer valuation, sector context and other Stocks in News.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Orchid Pharma Share Price rise today?
Ans. Orchid Pharma Share Price rose 6.04% today, but the supplied data does not establish a company-specific catalyst. The confirmed facts are the higher close, the intraday range and the turnover of Rs 0.61 Cr.
What is the current Orchid Pharma Share Price today?
Ans. Orchid Pharma Share Price today is Rs 1,048.85. The stock closed above its previous close of Rs 989.10 and finished the session at the day’s high, which makes the move easy to verify from the supplied data.
How much did Orchid Pharma rise today?
Ans. Orchid Pharma Share Price rose by Rs 59.75, or 6.04%, in the session. The day’s open was Rs 995.85 and the stock’s low was Rs 991.90 before closing at Rs 1,048.85.
What is Orchid Pharma’s market cap?
Ans. Orchid Pharma’s market capitalisation is Rs 5,923.25 Cr. In the supplied healthcare benchmark, that is above the sector median market cap of Rs 701.78 Cr, but below the average of Rs 13,926.75 Cr.
Is Orchid Pharma expensive compared with peers?
Ans. Orchid Pharma’s P/E ratio of 683.5 is far above the supplied peer figures and the sector median of 32.87. Its P/B ratio of 3.78 is closer to the sector range, but the earnings multiple is elevated.
How do Orchid Pharma’s returns compare with the sector?
Ans. Orchid Pharma’s ROE is 0.70% and ROCE is 1.11%, both below the supplied industry median and average. Those figures place the company well under the return ratios shown by the listed healthcare peers.
Recent Articles

Gujarat Gas (GUJENERGY) Share Price falls 2.1% to Rs 240.15 today
21 September 2026

Tarsons Products Ltd. (TARSONS): Tarsons Products Share Price Rises 10.55% as Stock Gains Today
21 September 2026

Ratnamani Metals & Tubes (RATNAMANI) Share Price Falls 2.16% Today
21 September 2026

Crown Lifters Ltd. (CROWN): Crown Lifters Share Price rises 10.62% to Rs 120: what the data shows
21 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gujarat Gas (GUJENERGY) Share Price falls 2.1% to Rs 240.15 today
Tarsons Products Ltd. (TARSONS): Tarsons Products Share Price Rises 10.55% as Stock Gains Today
Ratnamani Metals & Tubes (RATNAMANI) Share Price Falls 2.16% Today
Crown Lifters Ltd. (CROWN): Crown Lifters Share Price rises 10.62% to Rs 120: what the data shows
Bikewo Green Tech Ltd. Hits Upper Circuit on NSE, 21 September 2026
Popular this week
SAL Steel Ltd. (SALSTEEL): SAL Steel Share Price Near 52-Week High After 3.33% Rise

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





